Thematische Bibliographien / 229-238

Auswahl der wissenschaftlichen Literatur zum Thema „229-238“

Autor: Grafiati

Veröffentlicht am 26. Juli 2024

Zuletzt aktualisiert am 27. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Inhaltsverzeichnis

Zeitschriftenartikel
Bücher
Buchteile
Konferenzberichte

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "229-238" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "229-238"

Zhang, Xue-Qian, JuFang Wang, Lois L. Carl, Jianliang Song, Belinda A. Ahlers und Joseph Y. Cheung. „Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain“. American Journal of Physiology-Cell Physiology 296, Nr. 4 (April 2009): C911—C921. http://dx.doi.org/10.1152/ajpcell.00196.2008.

Der volle Inhalt der Quelle

Annotation:

Phospholemman (PLM) belongs to the FXYD family of small ion transport regulators. When phosphorylated at Ser68, PLM inhibits cardiac Na+/Ca2+ exchanger (NCX1). We previously demonstrated that the cytoplasmic tail of PLM interacts with the proximal intracellular loop (residues 218–358), but not the transmembrane (residues 1–217 and 765–938) or Ca2+-binding (residues 371–508) domains, of NCX1. In this study, we used intact Na+/Ca2+ exchanger with various deletions in the intracellular loop to map the interaction sites with PLM. We first demonstrated by Western blotting and confocal immunofluorescence microscopy that wild-type (WT) NCX1 and its deletion mutants were expressed in transfected HEK-293 cells. Cotransfection with PLM and NCX1 (or its deletion mutants) in HEK-293 cells did not decrease expression of NCX1 (or its deletion mutants). Coexpression of PLM with WT NCX1 inhibited NCX1 current ( INaCa). Deletion of residues 240–679, 265–373, 250–300, or 300–373 from WT NCX1 resulted in loss of inhibition of INaCa by PLM. Inhibition of INaCa by PLM was preserved when residues 229–237, 270–300, 328–330, or 330–373 were deleted from the intracellular loop of NCX1. These results suggest that PLM mediated inhibition of INaCa by interacting with two distinct regions (residues 238–270 and 300–328) of NCX1. Indeed, INaCa measured in mutants lacking residues 238–270, 300–328, or 238–270 + 300–328 was not affected by PLM. Glutathione S-transferase pull-down assays confirmed that PLM bound to fragments corresponding to residues 218–371, 218–320, 218–270, 238–371, and 300–373, but not to fragments encompassing residues 250–300 and 371–508 of NCX1, indicating that residues 218–270 and 300–373 physically associated with PLM. Finally, acute regulation of INaCa by PLM phosphorylation observed with WT NCX1 was absent in 250–300 deletion mutant but preserved in 229–237 deletion mutant. We conclude that PLM mediates its inhibition of NCX1 by interacting with residues 238–270 and 300–328.